Marijuana - Companies & Stocks

[TheFinalCD]

$CGC $TLRY $ACB $FLGC $SNDL https://t.co/24vzreaCgy@Greatstockpix @greatstockpicks@MoonMarket_ @greatstockpicks @MONEYEMPIRE @augustafriends @MarkBagger @stockplaymaker1 @BULLISHWIRE @Bullish_Trades @TopStockAlerts1 @IncredibleTrade@TheBull_Stocks @TheStockDon @Maximus_Holla…

— THE FINAL COUNTDOWN (@READY_2_PROFIT) March 27, 2024

[FinlayS00]

$EDXC - Endexx Corporation is poised for massive success in the plant-based wellness and vape market. With expansions across the Middle East and Europe, their HYLA division is capturing diverse consumer bases. Plus, upcoming name and symbol change signals a potential surge in stock performance. Get in now before the market catches on!

https://marketsherald.com/vaping-the-future-why-endexxs-hyla-maybe-the-next-big-wave-in-your-investment-portfolio/

[Hunchbackgeek]

OGI~"Organigram to Enter German Market Supplying Sanity Group"......

"Organigram to Enter German Market Supplying Sanity Group"
May 23rd, 2023 https://investors.organigram.ca/press-releases/organigram-to-enter-german-market-supplying-sanity-group

"Organigram to Enter German Market Supplying Sanity Group"

Organigram to supply the medical division of German cannabis company Sanity Group with high-quality medical flower for distribution in Germany.
Germany is expected to legalize recreational cannabis and remains the largest addressable cannabis market in Europe as a result.
Both Organigram and Sanity Group have received strategic investments from BAT

Toronto May 23, 2023 -- Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce today that it has entered into a supply agreement (“the Agreement”) for dried flower with the medical division of German cannabis company Sanity Group, a health and life sciences company based in Berlin, Germany, dedicated to the medical applications of cannabinoids. Through exports from its flagship state-of-the-art cultivation facility in Moncton, Organigram already services medical patients in Israel and Australia, and will now add Germany to its growing list of international markets.

Under the terms of the Agreement, the Company will provide high-quality, indoor-grown dried flower product to Sanity Group and grant Sanity Group strain exclusivity on certain genetics.

“With the German cannabis industry slowly moving toward a recreational adult-use model, we are excited to begin solidifying our relationships with reputable medical cannabis product developers and distributors like Sanity Group”, says Beena Goldenberg, Chief Executive Officer of Organigram. “We are committed to providing customers and medical patients in Australia, Israel, and now Germany, with high-quality cannabis, produced through industry-leading research, development and consumer-led insights.”

“We look forward to bringing Organigram’s high-quality indoor-grown flower to our German medical patients,” said Finn Age Hänsel, Managing Director & Founder of Sanity Group. “Organigram consistently ranks as a leader in flower sales nationally in Canada and will be providing us with exclusivity on certain strains within the German market.”

Activities under the Agreement are subject to compliance with all applicable laws, including receipt of all requisite approvals from Health Canada, the German Ministry of Health, and any other applicable regulatory authorities.

About Sanity Group
Berlin-based Sanity Group aims to improve people’s quality of life through the use of cannabinoids and the endocannabinoid system. In addition to pharmaceuticals, the focus is also on wellbeing and cosmetic products that utilize cannabinoids. Sanity Group, founded in Berlin in 2018 by Finn Age Hänsel and Fabian Friede, includes Vayamed and AVAAY Medical (medicinal cannabis), Endosane Pharmaceuticals (finished pharmaceuticals), Belfry Medical (medical products and digital applications), VAAY (wellbeing) and This Place (natural cosmetics). Near Frankfurt am Main, Sanity Group also operates a production and processing facility for cannabis extracts. More information can be found on sanitygroup.com/press.

About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include: Organigram Inc. and Laurentian Organic Inc., licensed producers of cannabis and cannabis-derived products in Canada, and The Edibles and Infusions Corporation, a licensed manufacturer of cannabis-infused edibles in Canada.

Organigram is focused on producing high-quality, cannabis for patients and adult recreational consumers, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

Forward-Looking Information
This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include changes to market conditions, consumer preferences and regulatory climate, and factors and risks as disclosed in the Company’s most recent annual information form, management’s discussion and analysis and other Company documents filed from time to time on SEDAR (see www.sedar.com) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. This news release contains information concerning the cannabis industry and the markets in which the Company operates, including market position and market share, which is based on information from independent third-party sources. Although we believe these sources to be generally reliable, market and industry data is inherently imprecise, subject to interpretation and cannot be verified with complete certainty due to limits on the availability and reliability of raw data, the voluntary nature of the data gathering process, and other limitations and uncertainties inherent in any statistical survey or data collection process. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.


For media enquiries:
Paolo De Luca
Chief Strategy Officer
[e-mail]

For investor enquiries:
Max Schwartz
Director of Investor Relations
[e-mail]

[Hunchbackgeek]

Happy 420 Day OGI https://vancouver.citynews.ca/2023/04/19/vancouver-4-20-events/

[DarthYoda]

"Democrats Plan to Take Another Pass at Cannabis Banking Bill":
MARCH 7, 2023
"A Republican Senate aide confirmed that Sen. Cynthia Lummis, a Wyoming Republican, is co-sponsoring a marijuana banking bill with Democratic Banking Chairman Sherrod Brown of Ohio. A cannabis industry source said the bill could be made public later this month."
https://www.route-fifty.com/public-safety/2023/03/democrats-plan-take-another-pass-cannabis-banking-bill/383711/

[Frog77]

M Marijuana better known as ghonja, as a topical, works Amazingly as a migraine medicine. Jmho. dazed inc Recent updates.. MEDH

Grand Opening for the Albuquerque, New Mexico store will be April 20th 2023. 420!!!! #consumptionlounge #cannabisandcoffee $medh @lazydazeco @DazedBrands We had our community meeting last week for our the conditional license. 30 days for comments. #LFG

— the 1 & Only HANS (@The1OnlyHans) February 28, 2023

Update on reporting and fins #soon$medh

— the 1 & Only HANS (@The1OnlyHans) February 28, 2023

Update for Ticket Symbol Change @DazedBrands $medh => $daze ... still pending with FINRA. Anyday now! Taking longer than anticipated. Appreciate the patience. #potstocks #weedstocks #OTC #cannabis #coffee #consumptionlounge

— the 1 & Only HANS (@The1OnlyHans) February 28, 2023

Pflugerville reboot. Sneak peek! Commencing #LFG watch this!!! We gonna do this one quick! It's gonna like awesome$medh @lazydazeco @DazedBrands Even my little girl getting in the work! #Entrepreneurship pic.twitter.com/DyTGYk5GU7

— the 1 & Only HANS (@The1OnlyHans) February 24, 2023

MEDH





have a good weekend.

[DarthYoda]

$CWBHF-New twitter policy..."Elon Musk Takes Twitter To Another Level: Greenlights Paid Ads For Cannabis & THC Products In US":
February 15, 2023
https://www.benzinga.com/markets/cannabis/23/02/30922774/elon-musk-takes-twitter-to-another-level-greenlights-paid-ads-for-cannabis-thc-products-in-us

"Twitter’s New Marijuana Advertising Policy Still Doesn’t Allow Ads For Marijuana Product Sales":
February 15, 2023

"“Advertisers may not promote or offer the sale of Cannabis (including CBD– cannabinoids),” it says. The exception is ads for “topical (non-ingestible) hemp-derived CBD topical products containing equal to or less than the 0.3 percent THC government-set threshold.”

https://www.marijuanamoment.net/twitters-new-marijuana-advertising-policy-still-doesnt-allow-ads-for-marijuana-product-sales/

[Drugdoctor]

$AKAN.32 - Overseas Marijuana NASDAQ Stock doesn't need Safe Banking. Operating in Germany, Portugal, and United Kingdom, just announced first revenues. Needs $1 price to maintain Nasdaq listing.

[Drugdoctor]

$SHWZ$1.54-Annotated-chart shows price at resistance 50-day-moving-average. If price can break through here and close higher, technical traders may declare a confirmed uptrend and continue the trend...

[DarthYoda]

"New GOP Congressional Panel Chairman Plans To Grill FDA On Lack Of Hemp And CBD Regulations":
Published 14 mins ago on January 12, 2023

https://www.marijuanamoment.net/new-gop-congressional-panel-chairman-plans-to-grill-fda-on-lack-of-hemp-and-cbd-regulations/

[Hunchbackgeek]

GREAT NEWS DarthYoda! Thank bud

[DarthYoda]

First Recreational dispensaries open in NY today at 4:20pm...

https://www.marijuanamoment.net/new-yorks-first-legal-recreational-marijuana-shop-will-open-at-420-today-officials-announce/

[Hunchbackgeek]

OGI~Organigram wins Cannabis Company of the Year Award......
Organigram wins KIND Magazine’s Cannabis Company of the Year Award and Most Innovative Product of the Year for Edison JOLTS (December 8th, 2022)
Toronto, Ontario – Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of a leading licensed producer of cannabis (the “Company” or “Organigram”), is pleased to announce it has won KIND Magazine’s (“KIND”) Cannabis Company of the Year award. Considered KIND’s marquee award, Cannabis Company of the Year is presented to the licensed producer that the KIND editorial team believes demonstrates the best combination of people, purpose, and product in a given year.

“We are very proud to be recognized by KIND Magazine,” says Beena Goldenberg, CEO, Organigram. “The Cannabis Company of the Year award is particularly special because it not only acknowledges Organigram as a top performing licensed producer, but also celebrates the high-quality of our talented employees from coast-to-coast. Likewise, the award is unique as it considers ‘purpose’, recognizing Organigram’s commitment to doing good in the communities we serve.”

In addition to the Cannabis Company of the Year award, the Company’s Edison Cannabis Co. brand’s Edison JOLTS, Canada’s first high-potency lozenge, received the Most Innovative Product of the Year. This award is voted on by budtenders and retail owners from across Canada.

“We are excited to receive these accolades from some of the most influential voices in the industry, including both the KIND editorial team and our industry’s retailers and budtenders,” says Eric Williams, Senior Director of Marketing, Organigram. “We share KIND’s commitment to making cannabis a part of Canadian culture and are proud to be recognized by the hard-working retailers and talented budtenders who bring their expertise and passion to support Canadians’ experience of our products every day.”

Organigram was nominated in two other categories including Hash of the Year for the Company’s Tremblant Hash and CBD Brand of the Year for its wellness brand, Monjour.

“It felt great to select Organigram for our KIND Cannabis Company of the Year because they do everything with love — you just know it's a company that cares for our community,” says Joshua Nagel, Founder & Chief Dream Officer at KIND. “They had an impressive year, both from a financial and market share growth perspective, and have also built beloved consumer brands including Edison, SHRED and Big Bag o’ Buds, but that's just the half of it. They're also great human beings to work with and we were impressed with their commitment to helping their local communities: Organigram is the kind of company that makes all of us at KIND happy to be working in weed.”

For more information about Organigram or its brands, please visit organigram.ca

About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include: Organigram Inc. and Laurentian Organic Inc., licensed producers of cannabis and cannabis-derived products in Canada, and The Edibles and Infusions Corporation, a licensed manufacturer of cannabis-infused edibles in Canada.

Organigram is focused on producing high-quality, cannabis for patients and adult recreational consumers, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Holy Mountain, Wo La, Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

Forward-Looking Information
This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include changes to market conditions and consumer preferences, and factors and risks as disclosed in the Company’s most recent annual information form, management’s discussion and analysis and other Company documents filed from time to time on SEDAR (see www.sedar.com) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.

For Investor Relations enquiries:
[e-mail]

For Media enquiries:
Paolo De Luca
[e-mail]
Chief Strategy Officer, Organigram
SOURCE: https://investors.organigram.ca/press-releases/organigram-wins-kind-magazines-cannabis-company-of-the-year-award-and-most

.

[Hunchbackgeek]

Thanks, BottomBounce! Hemp and Cannabis stocks are really... going to have a super bounce when it hits! I always love to pick up stocks this time of year. I have been picking up OGI shares, it is all so undervalued right now!

[DarthYoda]

https://s3.documentcloud.org/documents/23506988/2022-12-22-letter-urging-recognition-of-merits-of-descheduling-1_0.pdf

[BottomBounce]

$CGC has $1.48 Billion DEBT

[BottomBounce]

$HEMP Currently, 47 of the 50 U.S. states — as well as the District of Columbia — have legalized the sale and use of hemp-derived CBD products. $HEMP

[Hunchbackgeek]

OGI Investor Presentation... https://investors.organigram.ca/sites/default/files/documents/Organigram_Q4%20Investor_Presentation.pdf


.

[BottomBounce]

Hemp Batteries $ALYI is engaged in a long-term hemp battery initiative. Hemp has demonstrated potential to offer a very cost-effective superior material to traditional graphene in the production of super capacitors. Side by side comparison of hemp solutions to lithium battery solutions have shown favorable results for the potential of hemp. ALYI's hemp battery initiative has benefitted from notable industry leadership in the hemp super capacitor research field.

[DarthYoda]

https://www.benzinga.com/markets/cannabis/22/12/30165265/finally-legal-cannabis-sales-will-begin-in-the-big-apple-dec-29-gov-hochul-announces

[DarthYoda]

Well, I'll be taking requests as long as happy hour is going till Jan 1st. That's unlimited ammo. Lemme know about some good targets. I've got coffee, weed, time, keyboard, mouse, and LOTS of motivation. Let's not waste it.

[DarthYoda]

And if you don't care to participate, that's fine, no worries, but I'll be taking requests in case anyone can think of any good targets for me.

[DarthYoda]

As long as the feds and their corporate partners keep weed down, I will be going to war with their favorite stocks. Everyone in the weed sector should do the same IMO. Squeaky wheels get the oil. So let's all start squeaking in a way that hits em where it hurts. They want to demoralize us, but we need to channel that right back into their faces with extra mustard.

[Hunchbackgeek]

OGI Revenue beats by $13.45M......

Organigram reports Q4 results; issues FY23 soft guidance

Nov. 29, 2022 OrganiGram Holdings Inc. (OGI),

Organigram press release (NASDAQ:OGI):

Q4 net loss was $6.1M, compared to a net loss of $26.0M in Q4 Fiscal 2021.

Adjusted EBITDA of $3.2M, the third consecutive quarter of positive Adjusted EBITDA, compared to negative Adjusted EBITDA of $4.8M in the same prior year period.

Adjusted Gross Margin of $10.4M or 23%, compared to $3.0M or 12% in the same prior year period, reflecting improvements from increased efficiencies and higher sales volume.

Revenue of $45.5M (+82.7% Y/Y) beats by $13.45M.

Outlook: Organigram currently expects Fiscal 2023 revenue to be higher than that of Fiscal 2022.

The company expects to see an improvement in adjusted gross margins in Fiscal 2023 and has put measures in place that it expects will further improve margins over time.

The company expects significant growth in Adjusted EBITDA in Fiscal 2023 over Fiscal 2022.

The company expects to have positive cash flows from operating activities during Fiscal 2023 and positive free cash flows during calendar 2023.

https://seekingalpha.com/news/3911764-organigram-reports-q4-results-issues-fy23-soft-guidance?mailingid=29829239&messageid=2900&serial=29829239.64&utm_campaign=rta-stock-news&utm_content=link-1&utm_medium=email&utm_source=seeking_alpha&utm_term=29829239.64

Special thanks to John1311 for this.

[Drugdoctor]

$SHWZ$1.95-CEO-Insider-Buys-NET-PROFITS-Marijuana-Stock-HUGE-RALLY>>

[DarthYoda]

"Senate Sends Marijuana Research Bill To Biden’s Desk, With Schumer Saying He’s Having ‘Productive Talks’ On Broader Reform":
November 16, 2022
https://www.marijuanamoment.net/senate-lifts-hold-on-house-passed-marijuana-research-bill-with-expedited-vote-expected-soon/

[DarthYoda]

Aside from $CWBHF, $BTI is also invested in $OGI...

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170460228

[Drugdoctor]

$SHWZ$1.45-Marijuana-stock-Exploded-27%-higher-yesterday-on-high-volume! CHART>>

[DarthYoda]

$SHWZ been doing very well. Check out $CWBHF+$BTI...

BTI=British American Tobacco

Effective as of November 14, 2022, we entered into a subscription agreement with BT DE Investments, Inc. a wholly-owned subsidiary of BAT Group (LSE: BATS and NYSE: BTI), providing for the issuance of an approximately $56.8 million convertible debenture (the “Debenture”) is convertible into 19.9% ownership of the Company’s common shares at a conversion price of C$2.00 per common share of the Company on the Toronto Stock Exchange (TSX). The Debenture will accrue interest at an annualized rate of 5% until such time that there is federal regulation permitting the use of CBD as an ingredient in food products and dietary supplements in the United States. Following federal regulation of CBD, the annualized rate of interest shall reduce to 1.5%. The maturity date for the Debenture shall be November 2029. The Subscription Agreement contains customary representations and warranties and covenants. The funds from this Debenture can be used for operating purposes to fund the Company, as approved by the board of directors or in accordance with the Company’s board-approved budget.

https://www.otcmarkets.com/filing/html?id=16201884&guid=Ly_-kFBCz96Iyih

[Drugdoctor]

$SHWZ $1.23 -Marijuana**EARNINGS**Wed-Nov9th-RECORD-PROFITS>>

and RECORD SALES expected for this report... Here is the chart and last QTR results.

Here is the link for the conference call.

https://app.webinar.net/x0q6rpnP84n

[Frog77]

Just Approved for MJ consumption lounge DAZED INC

Medh - Name and symbol change form submitted + DAZE

https://twitter.com/The1OnlyHans Ceo

https://twitter.com/lazydazeco shops up and running

https://www.otcmarkets.com/stock/MEDH/security

Low float / pps for a stock about to go into actual marijuana retail stores.

Just one to keep an eye on
Charts https://schrts.co/KbMffiMG

Dazed inc

[Drugdoctor]

((MARIJUANA STOCKS are SMOKIN HOT today!! $SHWZ$1.30 is one of the most PROFITABLE and fast growing of all the USA weed stocks and it hasn't moved yet. Time to check it out folks...

Earnings in just 2 weeks and here are the last quarter RECORD REVENUES and profits. Similar results expected with this report, and I don't think the stock will be selling for just $1.30 then!

[Drugdoctor]

$SHWZ$1.30 Another BLOWOUT EARNINGS expected>>

$SHWZ moving up as expected GREAT EARNINGS continue to near...

Since Schwazze closed out the quarter 3 with a small loss in stock price, there will be a positive impact on the derivative impact of it's convertible debts... And with more New Mexico and Colorado locations opening, RECORD REVENUES should be expected.

There will be some charges related to acquisitions, but I expect another NET PROFITABLE quarter to be reported...

In case we have forgotten, here are the results of 2nd qtr

[FinlayS00]

$EDXC - Endexx Corporation has received hemp distribution authorization from four states – Louisiana, Alaska, Texas, and Iowa – which are known to have more detailed and strict requirements.

https://finance.yahoo.com/news/endexx-achieves-distribution-registration-hemp-120000602.html

[DarthYoda]

"Most Americans Say Alcohol And Tobacco Are More Dangerous Than Marijuana, Poll Finds":
October 24, 2022

NATIONAL POLL: Is #marijuana more dangerous than alcohol or tobacco?

ALCOHOL:
7% marijuana more
54% alcohol more
38% equally dangerous

TOBACCO:
13% marijuana more
45% tobacco more
38% equally dangeroushttps://t.co/d1yiM6axx7

— MonmouthPoll (@MonmouthPoll) October 24, 2022

https://www.marijuanamoment.net/most-americans-say-alcohol-and-tobacco-are-more-dangerous-than-marijuana-poll-finds/

[DarthYoda]

"Cannabis must be removed from the Controlled Substances Act":
10/21/22
https://thehill.com/opinion/healthcare/3698458-cannabis-must-be-removed-from-the-controlled-substances-act/

[DarthYoda]

Anything less would be uncivilized...

If Congress chose to remove marijuana from the CSA entirely, it could seek to regulate and tax commercial marijuana activities.

https://crsreports.congress.gov/product/pdf/IN/IN11204

[DarthYoda]

Options for Congress
Congress could choose to maintain the federal prohibition on marijuana, but if it wanted to address the
Schedule I status, it could do a number of things: (1) amend the CSA to move marijuana to a less
restrictive schedule; (2) create an entirely new schedule or other category for marijuana; or (3) remove it
entirely from the CSA. If marijuana remains a controlled substance under the CSA under any schedule,
that would maintain the existing conflict between the federal government and states that have legalized
recreational marijuana, though moving marijuana to a less restrictive schedule could help mitigate
conflicts between federal law and state medical marijuana laws. The creation of a new schedule solely for
marijuana would give Congress an opportunity to modify the criminality of marijuana under the CSA. If
Congress chose to remove marijuana from the CSA entirely, it could seek to regulate and tax commercial
marijuana activities.

https://crsreports.congress.gov/product/pdf/IN/IN11204

[DarthYoda]

https://crsreports.congress.gov/product/pdf/IN/IN11204

https://www.marijuanamoment.net/congressional-researchers-lay-out-marijuana-options-for-lawmakers-following-bidens-scheduling-directive/

[DarthYoda]

"White House Drug Czar Says Marijuana ‘Clearly’ Has Medical Value And Scheduling Review Must Follow Science":
October 18, 2022
https://www.marijuanamoment.net/white-house-drug-czar-says-marijuana-clearly-has-medical-value-and-scheduling-review-must-follow-science/

[DavidPro__1]

Marijuana is a Booming Business. The cannabis plant boasts many medicinal qualities. Thus, investors have welcomed the chance to invest in this promising industry.

[DarthYoda]

Aside from when $MJNA had licensed the Fed's patent 6630507 many years ago, this was another big factor that first got me into "pot stocks"...

I remember the stories from years ago about 4 people who were getting their weed directly from the U.S. Federal Government, and I swore that would help lead to Federal legalization much sooner than it has, but I would really like to know today how many people are getting their weed straight from the Feds. An update on that would be pretty cool in the current environment...

"4 Americans get medical pot from the feds":
SEPTEMBER 28, 2011

For the past three decades, Uncle Sam has been providing a handful of patients with some of the highest grade marijuana around. The program grew out of a 1976 court settlement that created the country's first legal pot smoker.

https://www.cbsnews.com/news/4-americans-get-medical-pot-from-the-feds/

[Drugdoctor]

$SHWZ-chart-showing-BULLISH RSI - MFI - and 50 day moving-average-breakout.

Not saying an uptrend has started, but the indicators are in the area where uptrends happen.

[DarthYoda]

Caffeine, alcohol, and tobacco are not on the CSA at all. All 3 can kill you. All 3 have high levels of abuse, and none of them are prescribed or even recommended by doctors for any medical uses...

A lethal amount of caffeine is about 180 mg/L, which has been determined by examining the blood of patients who died from overdose. When you consume ~100 mg of caffeine, it raises your blood caffeine levels by about 5 mg/L, meaning it’ll take almost 40 cups of coffee to be lethal.

https://www.mcgill.ca/oss/article/health-and-nutrition-you-asked/how-many-yerbas-does-it-take-overdose-caffeine#:~:text=A%20lethal%20amount%20of%20caffeine,patients%20who%20died%20from%20overdose.

[oystersnbeer]

“Biden seemed an enemy to the cannabis industry not long ago, but now it appears it was only due to needing the right moment for his true intentions to emerge.”

America needs it.
A harmless chill pill, that promotes non-violence.

[DarthYoda]

Agreed, thanks. It's time for an end to the never ending theatrics of what should simply be people doing their job. Time to put up or shut up. Legalize it, decriminalize it, or prepare for a war, because the "excitement" about what schedule a plant is has been milked to death.

[neophyte184]

The monster sector boom is coming Darth! As we know, timing is everything in politics. Biden seemed an enemy to the cannabis industry not long ago, but now it appears it was only due to needing the right moment for his true intentions to emerge.

Prepare for the overturning of the CSA in the relative near future. Perhaps even a descheduling of cannabis federally.

Best,

Neo

[neophyte184]

Nice! Thank you for that Darth. Charlotte's Web is a trailblazer in the industry.

[DarthYoda]

Just to go apples to apples, yes, the coca plant itself is also schedule 2. That goes for the opium poppy plant as well...

"§ 1308.12 Schedule II.":

(3) Opium poppy and poppy straw.

(4) Coca leaves (9040) and any salt, compound, derivative or preparation of coca leaves (including cocaine (9041) and ecgonine (9180) and their salts, isomers, derivatives and salts of isomers and derivatives), and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include:

(i) Decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine; or

(ii) [123I]ioflupane.

(5) Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy), 9670.

https://www.ecfr.gov/current/title-21/chapter-II/part-1308/subject-group-ECFRf62f8e189108c4d/section-1308.12

[DarthYoda]

Pretty low bar..."a topical local anesthetic for the upper respiratory tract."...that's all...

Cocaine is a Schedule II drug under the Controlled Substances Act, meaning it has a high potential for abuse and has an accepted medical use for treatment in the United States. Cocaine hydrochloride solution (4 percent and 10 percent) is used primarily as a topical local anesthetic for the upper respiratory tract.

https://www.dea.gov/sites/default/files/2020-06/Cocaine-2020_1.pdf